BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24100448)

  • 1. Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects.
    Stockley J; Morgan NV; Bem D; Lowe GC; Lordkipanidzé M; Dawood B; Simpson MA; Macfarlane K; Horner K; Leo VC; Talks K; Motwani J; Wilde JT; Collins PW; Makris M; Watson SP; Daly ME;
    Blood; 2013 Dec; 122(25):4090-3. PubMed ID: 24100448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spotlight on FLI1, RUNX1, and platelet dysfunction.
    Rao AK
    Blood; 2013 Dec; 122(25):4004-6. PubMed ID: 24335028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective acid hydrolase secretion in RUNX1 haplodeficiency: Evidence for a global platelet secretory defect.
    Rao AK; Poncz M
    Haemophilia; 2017 Sep; 23(5):784-792. PubMed ID: 28662545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of PLDN (pallidin) is a mechanism for platelet dense granule deficiency in RUNX1 haplodeficiency.
    Mao GF; Goldfinger LE; Fan DC; Lambert MP; Jalagadugula G; Freishtat R; Rao AK
    J Thromb Haemost; 2017 Apr; 15(4):792-801. PubMed ID: 28075530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations.
    Antony-Debré I; Bluteau D; Itzykson R; Baccini V; Renneville A; Boehlen F; Morabito M; Droin N; Deswarte C; Chang Y; Leverger G; Solary E; Vainchenker W; Favier R; Raslova H
    Blood; 2012 Sep; 120(13):2719-22. PubMed ID: 22677128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects.
    Fletcher SJ; Johnson B; Lowe GC; Bem D; Drake S; Lordkipanidzé M; Guiú IS; Dawood B; Rivera J; Simpson MA; Daly ME; Motwani J; Collins PW; Watson SP; Morgan NV;
    J Clin Invest; 2015 Sep; 125(9):3600-5. PubMed ID: 26280575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular phenotype and bleeding risks of an inherited platelet disorder in a family with a RUNX1 frameshift mutation.
    Badin MS; Iyer JK; Chong M; Graf L; Rivard GE; Waye JS; Paterson AD; Pare G; Hayward CPM
    Haemophilia; 2017 May; 23(3):e204-e213. PubMed ID: 28181366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4 gene expression in combination with ETS family proteins.
    Okada Y; Watanabe M; Nakai T; Kamikawa Y; Shimizu M; Fukuhara Y; Yonekura M; Matsuura E; Hoshika Y; Nagai R; Aird WC; Doi T
    J Thromb Haemost; 2013 Sep; 11(9):1742-50. PubMed ID: 23848403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency.
    Jalagadugula G; Mao G; Kaur G; Goldfinger LE; Dhanasekaran DN; Rao AK
    Blood; 2010 Dec; 116(26):6037-45. PubMed ID: 20876458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and platelet phenotype in a family with RUNX1 mutated thrombocytopenia.
    Perez Botero J; Chen D; Cousin MA; Majerus JA; Coon LM; Kruisselbrink TM; Klee EW; Lazaridis KN; Pruthi RK; Patnaik MM
    Leuk Lymphoma; 2017 Aug; 58(8):1963-1967. PubMed ID: 27931139
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1.
    Jalagadugula G; Mao G; Kaur G; Dhanasekaran DN; Rao AK
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):921-7. PubMed ID: 21252065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation.
    Bluteau D; Balduini A; Balayn N; Currao M; Nurden P; Deswarte C; Leverger G; Noris P; Perrotta S; Solary E; Vainchenker W; Debili N; Favier R; Raslova H
    J Clin Invest; 2014 Feb; 124(2):580-91. PubMed ID: 24430186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1.
    Stevenson WS; Rabbolini DJ; Beutler L; Chen Q; Gabrielli S; Mackay JP; Brighton TA; Ward CM; Morel-Kopp MC
    Blood; 2015 Oct; 126(17):2027-30. PubMed ID: 26316623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective α-granule secretion.
    Langer F; Obser T; Oyen F; Spath B; Holstein K; Greinacher A; White JG; Budde U; Bokemeyer C; Schneppenheim R
    Thromb Haemost; 2014 Apr; 111(4):777-9. PubMed ID: 24337418
    [No Abstract]   [Full Text] [Related]  

  • 15. NF-E2, FLI1 and RUNX1 collaborate at areas of dynamic chromatin to activate transcription in mature mouse megakaryocytes.
    Zang C; Luyten A; Chen J; Liu XS; Shivdasani RA
    Sci Rep; 2016 Jul; 6():30255. PubMed ID: 27457419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrothrombocytopenia and dense granule deficiency associated with FLI1 variants: ultrastructural and pathogenic features.
    Saultier P; Vidal L; Canault M; Bernot D; Falaise C; Pouymayou C; Bordet JC; Saut N; Rostan A; Baccini V; Peiretti F; Favier M; Lucca P; Deleuze JF; Olaso R; Boland A; Morange PE; Gachet C; Malergue F; Fauré S; Eckly A; Trégouët DA; Poggi M; Alessi MC
    Haematologica; 2017 Jun; 102(6):1006-1016. PubMed ID: 28255014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet transcriptome analysis in patients with germline RUNX1 mutations.
    Palma-Barqueros V; Bastida JM; López Andreo MJ; Zámora-Cánovas A; Zaninetti C; Ruiz-Pividal JF; Bohdan N; Padilla J; Teruel-Montoya R; Marín-Quilez A; Revilla N; Sánchez-Fuentes A; Rodriguez-Alen A; Benito R; Vicente V; Iturbe T; Greinacher A; Lozano ML; Rivera J; ;
    J Thromb Haemost; 2023 May; 21(5):1352-1365. PubMed ID: 36736831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets.
    Glembotsky AC; Bluteau D; Espasandin YR; Goette NP; Marta RF; Marin Oyarzun CP; Korin L; Lev PR; Laguens RP; Molinas FC; Raslova H; Heller PG
    J Thromb Haemost; 2014 May; 12(5):761-72. PubMed ID: 24606315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia.
    Antony-Debré I; Manchev VT; Balayn N; Bluteau D; Tomowiak C; Legrand C; Langlois T; Bawa O; Tosca L; Tachdjian G; Leheup B; Debili N; Plo I; Mills JA; French DL; Weiss MJ; Solary E; Favier R; Vainchenker W; Raslova H
    Blood; 2015 Feb; 125(6):930-40. PubMed ID: 25490895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders.
    Latger-Cannard V; Philippe C; Bouquet A; Baccini V; Alessi MC; Ankri A; Bauters A; Bayart S; Cornillet-Lefebvre P; Daliphard S; Mozziconacci MJ; Renneville A; Ballerini P; Leverger G; Sobol H; Jonveaux P; Preudhomme C; Nurden P; Lecompte T; Favier R
    Orphanet J Rare Dis; 2016 Apr; 11():49. PubMed ID: 27112265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.